ALGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

ALIGN TECHNOLOGY INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$149.00+1.69 (+1.15%)

Close on Oct 19, 2026

Market cap: $10.66B
P/E (TTM): 25.9
Dividend yield: –

ALIGN TECHNOLOGY INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	4,035	3,999	3,862	3,735	3,953	2,472	2,407	1,966	1,473	1,080	845	762	660	560	480	387	312	304
Cost of Revenue	1,324	1,200	1,155	1,101	1,017	709	663	519	356	265	205	183	162	144	118	84	79	79
Gross Profit	2,711	2,799	2,707	2,634	2,935	1,763	1,744	1,448	1,117	815	640	578	498	416	361	303	233	225
Research & Development	370	364	347	305	250	175	157	129	98	76	61	53	44	43	37	26	22	26
Selling, General & Admin	1,756	1,763	1,703	1,674	1,709	1,201	1,072	852	–	–	390	332	293	251	234	179	174	177
Selling & Marketing	–	–	–	–	–	–	1,072	852	666	491	390	332	180	152	142	114	113	115
General & Administrative	–	–	–	–	–	–	–	–	–	–	–	115	113	99	92	65	62	62
Advertising Expenses	189	185	201	222	326	161	119	88	70	36	23	27	26	24	21	20	18	–
Operating Expenses	2,165	2,192	2,064	1,991	1,959	1,376	1,201	981	763	566	451	385	404	331	271	201	268	210
Operating Income	546	608	643	643	976	387	542	467	354	249	189	194	94	86	90	103	-34	16
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.05	0.02	0.09	0.02
Interest & Investment Income	16	20	17	5.37	3.10	3.13	12	8.58	–	–	–	–	–	0.76	0.55	0.56	0.58	3.05
Income from Equity Investments	–	–	–	–	0	0	-7.53	-8.69	-3.22	-1.68	0	0	–	–	–	–	–	–
Other Non-Operating Income	23	-19	-19	-49	33	-11	7.68	-8.49	4.24	-11	-2.53	-3.21	-1.07	-1.30	-0.42	-1.29	–	–
Merger & Restructuring Charges	–	37	14	10	–	–	–	–	–	–	–	–	–	–	–	–	1.32	6.23
Asset Impairment Charges	0	0	0	0	0	0	28	0	0	0	0	0	41	37	0	0	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	-0.06	-0.04	-0.51
Legal Settlements	-4.18	-31	0	0	43	0	51	0	0	–	–	–	–	0	0	-4.55	-70	–
Pretax Income	585	609	641	599	1,012	379	563	467	365	243	186	190	93	84	90	102	-34	17
Income Tax Expense	175	188	196	237	240	-1,397	112	58	130	51	42	45	29	26	23	28	-2.62	-63
Net Income	410	421	445	362	772	1,776	443	400	231	190	144	146	64	59	67	74	-31	80
EPS (Basic)(per share)	5.66	5.63	5.82	4.62	9.78	22.55	5.57	5.00	2.89	2.38	1.80	1.81	0.80	0.73	0.86	0.98	-0.45	1.20
EPS (Diluted)(per share)	5.65	5.62	5.81	4.61	9.69	22.41	5.53	4.92	2.83	2.33	1.77	1.77	0.78	0.71	0.83	0.95	-0.45	1.18
Shares Outstanding (Basic, Weighted)(shares)	73	75	76	78	79	79	79	80	80	80	80	81	81	81	78	76	69	67
Shares Outstanding (Diluted, Weighted)(shares)	73	75	77	78	80	79	80	81	82	81	82	82	83	83	80	78	69	68
EBITDA	783	753	786	768	1,085	481	621	521	391	273	207	211	111	103	102	114	-24	25

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 68.0%
Operating margin: 13.2%
Net margin: 10.0%
Return on equity, FY2025: 10.4%

Financial strength

Current ratio: 1.40
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 57.8%

Valuation

P/E ratio: 25.9
Price to sales: 2.57
Price to book: 2.52
Dividend yield: –